Avego Healthcare Capital’s team includes 10 investment professionals, 1 operations personnel, and 2 admin related team members. The average tenure for the Firm’s senior team is 10 years.
Sign-up to view Avego Healthcare Capital’s full profile and discover more small growth capital firm investors just like it.
100 North Main Street, Suite 301,
Alpharetta,
Georgia
30009
United States
(646) 844-0030
www.avego.com
| Name | Title | Phone | Office | |
|---|---|---|---|---|
 |
Founder & Managing Partner | Alpharetta | ||
|
Mr. Venkataraman is an experienced operating executive in the specialty pharmaceutical industry. Most recently, Mr. Venkataraman was Co-Founder and Executive Chairman of Vidara Therapeutics until its sale to Horizon Pharma in 2014. Prior to founding Vidara Therapeutics, Mr. Venkataraman was the Co-Founder and CEO of Alaven Pharmaceutical from 2003 until its sale to Meda Pharma in 2010. Mr. Venkataraman also served as COO, CFO, and VP of Business Development, Strategic Planning and Operations at First Horizon Pharmaceutical (now Shionogi Pharma). Mr. Venkataraman has authored several papers in research publications related to medicinal chemistry and holds numerous drug and formulation patents. Mr. Venkataraman holds an MS in Chemistry from Case Western University and an MBA from the Wharton School of the University of Pennsylvania. |
||||
| Function: Investment | ||||
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
